![Disruption of Genes Encoding Putative Zwitterionic Capsular Polysaccharides of Diverse Intestinal Bacteroides Reduces the Induction of Host Anti-Inflammatory Factors | SpringerLink Disruption of Genes Encoding Putative Zwitterionic Capsular Polysaccharides of Diverse Intestinal Bacteroides Reduces the Induction of Host Anti-Inflammatory Factors | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00248-022-02037-1/MediaObjects/248_2022_2037_Fig1_HTML.png)
Disruption of Genes Encoding Putative Zwitterionic Capsular Polysaccharides of Diverse Intestinal Bacteroides Reduces the Induction of Host Anti-Inflammatory Factors | SpringerLink
![Antibakteriální ubrousky vlhčené BRIS (100 ks) - Hafyso - obalový materiál, igelitové pytle, mikroténové sáčky Antibakteriální ubrousky vlhčené BRIS (100 ks) - Hafyso - obalový materiál, igelitové pytle, mikroténové sáčky](https://cdn.myshoptet.com/usr/www.hafyso.cz/user/shop/big/1616_ubrousky.jpg?5e5f7d20)
Antibakteriální ubrousky vlhčené BRIS (100 ks) - Hafyso - obalový materiál, igelitové pytle, mikroténové sáčky
![Bristol Myers Squibb - U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis Bristol Myers Squibb - U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis](https://s25.q4cdn.com/566753351/files/doc_multimedia/Deucrava_US_Approval_Product_Shots.jpg)